{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P37231",
      "entity_text" : "PPARgamma",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "PPARgamma agonist is known to enhance insulin sensitivity and decrease hepatic glucose production in type 2 diabetes mellitus.",
  "reading_complete" : "2020-08-02T08:55:47Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T08:54:20Z",
  "trigger" : "decrease",
  "evidence" : [ "PPARgamma agonist is known to enhance insulin sensitivity and decrease hepatic glucose" ],
  "pmc_id" : "5743459",
  "score" : 0
}